US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist
  • 6.130
  • -0.030-0.49%
Close Feb 14 16:00 ET
  • 6.250
  • +0.120+1.96%
Post 20:01 ET
340.90MMarket Cap-3.31P/E (TTM)

Foghorn Therapeutics Key Stats

Foghorn Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.450M--
--2024/Q4-- / 8.270M--
--2024/Q37.808M / 7.010M--
--2024/Q26.888M / 6.726M--
--2024/Q15.050M / 7.352M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.450M--
--2024/Q4-- / 8.270M--
--2024/Q37.808M / 7.010M--
--2024/Q26.888M / 6.726M--
--2024/Q15.050M / 7.352M--

Unlock Free Earnings Estimates

Foghorn Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 8, 2025

Strong Buy

  • Buy

    83.33%
  • Hold

    16.67%
  • Sell

    0.00%

Price Target

No Data